MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore genetic testing's role in diagnosing and managing CPVT, a rare heart disorder. Learn how personalized medicine can transform cardiac care strategies.
Explore how genetic testing, especially whole exome sequencing, advances the diagnosis and understanding of Charcot-Marie-Tooth Disease Type 2, offering new hope.
Explore the role of genetic testing in diagnosing Charcot-Marie-Tooth disease type 4, aiding in precise diagnosis, personalized treatment, and family planning.
Explore how genetic testing enhances diagnosis and management of Charcot-Marie-Tooth disease type X, offering personalized treatment and family planning insights.
Explore how genetic testing helps diagnose childhood-onset autosomal recessive myopathy with ophthalmoplegia, guiding treatment and informing family planning.
Explore the genetic landscape of chromophobe renal cell carcinoma, enhancing diagnosis, treatment, and prognosis through genetic testing and personalized medicine.
Explore how genetic testing aids in diagnosing Chronic Granulomatous Disease, guiding treatment, and offering prognostic insights for improved patient care.
Explore CoQ10 deficiency, its link with hereditary hemochromatosis, and how genetic testing identifies mutations for tailored treatment and risk assessment.